The historical rank and industry rank for Becton Dickinson's Days Payable or its related term are showing as below:
BDX'
s Days Payable Range Over the Past 10 Years
Min: 36.43 Med: 50.96 Max: 63.38
Current: 63.38
During the past 13 years, Becton Dickinson's highest Days Payable was 63.38. The lowest was 36.43. And the median was 50.96.
BDX's Days Payable is ranked worse than 54.97% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs BDX: 63.38
Becton Dickinson's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
Becton Dickinson Days Payable Related Terms
Becton Dickinson Days Payable Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Days Payable distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Becton Dickinson's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (BDX) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Becton Dickinson and its competitors. Over the past decade, Becton Dickinson's Days Payable has ranged from 36.43 to 63.38. According to the industry distribution chart, Becton Dickinson ranks #437 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 55%.
Is Becton Dickinson's Days Payable too high?
Becton Dickinson's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 36.43 to a high of 63.38. Based on the distribution chart, Becton Dickinson ranks #437 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Days Payable compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #437 out of 795 companies for Days Payable. This places Becton Dickinson in the lower half of its industry. The industry median Days Payable is 67.87. Historically, Becton Dickinson's own Days Payable has ranged from 36.43 to 63.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $190.96, compared to a current price of $151.38 — trading 20.7% below its estimated fair value. The current Days Payable is 0.00. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Becton Dickinson (BDX), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $151.38 is trading 20.7% below its estimated GF Value™ of $190.96.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for BDX:
Days Payable: 0.00
GF Value™: $190.96 vs. price of $151.38 (20.7% below fair value)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score
Get the complete analysis for BDX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
